M&A

AstraZeneca Purchases FibroGen China for ~$160M

AstraZeneca Purchases FibroGen China for ~$160M

Shots: AstraZeneca has purchased FibroGen’s China subsidiary for ~$160M ($85...

Cosette Pharmaceuticals to Acquire Mayne Pharma for ~$430M

Cosette Pharmaceuticals to Acquire Mayne Pharma for ~$430M

Shots: Cosette Pharmaceuticals to acquire Mayne Pharma Group for ~$430M, with shar...

Novartis to Acquire Anthos Therapeutics for ~$3.1B

Novartis to Acquire Anthos Therapeutics for ~$3.1B

Shots: Novartis to acquire Anthos (launched by Blackstone Life Sciences & Nova...

Bain Capital to Acquire Mitsubishi Tanabe Pharma for ~$3.3B

Bain Capital to Acquire Mitsubishi Tanabe Pharma for ~$3.3B

Shots: Bain Capital has signed to acquire Mitsubishi Tanabe Pharma in a carve-out...

Alumis Signs a Definitive Merger Agreement with ACELYRIN to Develop Novel Therapies for Immune-mediated Diseases

Alumis Signs a Definitive Merger Agreement with ACELYRIN to Develop Novel Therapies for Immune-mediated Diseases

Shots: Alumis & ACELYRIN have entered into a definitive agreement to merge, wi...

Lantheus Holdings to Acquire Evergreen Theragnostics for ~$1B

Lantheus Holdings to Acquire Evergreen Theragnostics for ~$1B

Shots: Lantheus will acquire Evergreen Theragnostics for $250M upfront plus ~$752....

Image